Bridges Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.21M Buy
50,081
+3,250
+7% +$85K 0.01% 246
2026
Q1
$1.32M Sell
46,831
-4,400
-9% -$117K 0.02% 223
2025
Q4
$1.28M Buy
51,231
+18
+0% +$454 0.02% 217
2025
Q3
$1.3M Sell
51,213
-400
-0.8% -$9.87K 0.02% 222
2025
Q2
$1.25M Sell
51,613
-234
-0.5% -$5.46K 0.02% 222
2025
Q1
$1.31M Sell
51,847
-700
-1% -$18.3K 0.02% 210
2024
Q4
$1.39M Sell
52,547
-32,009
-38% -$868K 0.02% 174
2024
Q3
$2.45M Buy
84,556
+144
+0.2% +$4.2K 0.03% 137
2024
Q2
$2.36M Buy
84,412
+38,012
+82% +$1.05M 0.04% 133
2024
Q1
$1.29M Hold
46,400
0.04% 128
2023
Q4
$1.34M Sell
46,400
-3,500
-7% -$106K 0.04% 123
2023
Q3
$1.66M Sell
49,900
-2,464
-5% -$87.1K 0.06% 112
2023
Q2
$1.92M Sell
52,364
-200
-0.4% -$7.79K 0.06% 112
2023
Q1
$2.14M Sell
52,564
-2,100
-4% -$90.7K 0.08% 109
2022
Q4
$2.8M Sell
54,664
-1,901
-3% -$91.1K 0.1% 98
2022
Q3
$2.48M Sell
56,565
-936
-2% -$45.5K 0.1% 101
2022
Q2
$3.02M Sell
57,501
-800
-1% -$40.8K 0.11% 97
2022
Q1
$3.02M Sell
58,301
-2,599
-4% -$135K 0.09% 107
2021
Q4
$3.6M Sell
60,900
-759
-1% -$37.6K 0.11% 99
2021
Q3
$2.65M Sell
61,659
-197
-0.3% -$8.73K 0.08% 107
2021
Q2
$2.42M Sell
61,856
-996
-2% -$38.7K 0.07% 114
2021
Q1
$2.28M Sell
62,852
-5,317
-8% -$189K 0.07% 113
2020
Q4
$2.51M Sell
68,169
-8,417
-11% -$309K 0.08% 108
2020
Q3
$2.67M Sell
76,586
-1,050
-1% -$36.8K 0.09% 101
2020
Q2
$2.41M Sell
77,636
-8,659
-10% -$294K 0.09% 103
2020
Q1
$2.67M Sell
86,295
-36,006
-29% -$1.23M 0.12% 100
2019
Q4
$4.55M Sell
122,301
-498
-0.4% -$17.7K 0.17% 91
2019
Q3
$4.19M Sell
122,799
-17,377
-12% -$632K 0.16% 94
2019
Q2
$5.76M Sell
140,176
-20
-0% -$794 0.22% 81
2019
Q1
$5.65M Sell
140,196
-12,442
-8% -$498K 0.23% 83
2018
Q4
$6.32M Sell
152,638
-3,525
-2% -$146K 0.3% 75
2018
Q3
$6.53M Sell
156,163
-4,271
-3% -$164K 0.32% 73
2018
Q2
$5.52M Sell
160,434
-4,582
-3% -$157K 0.25% 80
2018
Q1
$5.56M Buy
165,016
+38,578
+31% +$1.33M 0.26% 76
2017
Q4
$4.34M Buy
126,438
+14,027
+12% +$478K 0.35% 65
2017
Q3
$3.81M Buy
112,411
+56,076
+100% +$1.8M 0.36% 63
2017
Q2
$1.8M Sell
56,335
-363
-0.6% -$11.4K 0.24% 73
2017
Q1
$1.84M Buy
56,698
+5,298
+10% +$167K 0.25% 71
2016
Q4
$1.58M Buy
51,400
+13,804
+37% +$421K 0.22% 74
2016
Q3
$1.21M Buy
37,596
+2,243
+6% +$75K 0.2% 78
2016
Q2
$1.18M Buy
35,353
+3,032
+9% +$96.8K 0.2% 78
2016
Q1
$909K Buy
32,321
+2,907
+10% +$83K 0.17% 79
2015
Q4
$901K Sell
29,414
-330
-1% -$10.4K 0.16% 79
2015
Q3
$946K Hold
29,744
0.16% 84
2015
Q2
$946K Sell
29,744
-4,771
-14% -$155K 0.16% 84
2015
Q1
$1.14M Sell
34,515
-487
-1% -$15.5K 0.2% 76
2014
Q4
$1.03M Buy
35,002
+1,840
+6% +$52.8K 0.18% 81
2014
Q3
$930K Buy
33,162
+12,134
+58% +$341K 0.17% 87
2014
Q2
$592K Buy
21,028
+3,361
+19% +$95.8K 0.11% 97
2014
Q1
$538K Buy
17,667
+4,321
+32% +$129K 0.11% 96
2013
Q4
$388K Sell
13,346
-1,633
-11% -$47.5K 0.09% 102
2013
Q3
$409K Buy
14,979
+569
+4% +$15.5K 0.1% 100
2013
Q2
$383K Buy
+14,410
New +$398K 0.1% 100

Other funds holding PFE

Bridges Investment Management's PFE Position: Q2 2026 in Review

Bridges Investment Management increased its Pfizer (PFE) stake by 6.9% in Q2 2026, buying an estimated $85K and bringing the position to 50,081 shares worth $1.21M. The position accounts for 0.01% of the portfolio, ranked #246.

Bridges Investment Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.53M in Q3 2018. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Bridges Investment Management held 50,081 shares of Pfizer worth $1.21M as of Q2 2026.
  • Bridges Investment Management bought 3,250 Pfizer shares in Q2 2026, an estimated $85K.
  • Pfizer made up 0.01% of Bridges Investment Management's portfolio in Q2 2026, its #246 holding.
  • Bridges Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Bridges Investment Management's Pfizer position peaked at $6.53M in Q3 2018.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Bridges Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.